|
TELO Telomir Pharmaceuticals Inc 1971532 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-990,947.00 |
| Balance Sheet |
|
Current Assets
|
$5,789,536.00 |
|
Assets
|
$5,789,536.00 |
|
Current Liabilities
|
$827,310.00 |
|
Liabilities
|
$827,310.00 |
|
Equity
|
$4,962,226.00 |
|
Shares Out
|
34380971.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,773,510.00 |
| Market Analysis |
Market Cap
|
$42,976,213.75 |
|
Price
|
$1.23 |
|
BVPS
|
0.14 |
|
PB
|
8.93 |
|
EPS
|
-0.03 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TELO documents filed with the SEC.
TELO Filings
Clear
